Purification of heat shock protein 70-associated tumor peptides and its antitumor immunity on hepatoma in mice

Table 4 Adoptive immunoprotective effect against HCaF challenge elicited by ISC transfer

Group	Survival rate (%)		Survival days of	Extended	Tumor wt. (g)	Spleen wt.(g)
	(No. of death/No. of mice challenged)		tumor-bearing mice (mean ± SD)	survival rate (%)	(mean ± SD)	(mean ± SD)
ISC	75	(2/8)a	50.5 ± 9.2b	71.0b	14.92 ± 0.42bc	0.39 ± 0.01bc
SC	0	(8/8)	36.8 ± 12.9	24.6	7.73 ± 2.14	0.18 ± 0.05
Chal. control	0	(8/8)	29.5 ± 3.9	0	7.35 ± 1.16	0.21 ± 0.05

^aP < 0.05, vs chal. Control;

^bP < 0.01, vs chal. Control;

^cP < 0.01, vs SC.